GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Enovix Corp (NAS:ENVX) » Definitions » Research & Development
中文

Enovix (Enovix) Research & Development : $88.39 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Enovix Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Enovix's Research & Development for the three months ended in Dec. 2023 was $34.58 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $88.39 Mil.

Enovix Research & Development Historical Data

The historical data trend for Enovix's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enovix Research & Development Chart

Enovix Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Research & Development
14.44 37.85 58.05 88.39

Enovix Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.55 23.75 16.55 13.51 34.58

Enovix Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $88.39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enovix  (NAS:ENVX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Enovix Research & Development Related Terms

Thank you for viewing the detailed overview of Enovix's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Enovix (Enovix) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Enovix Corp (NAS:ENVX) » Definitions » Research & Development
Comparable Companies
HOLI POWL EAF PLPC KE ENR HAYW BE FCEL FREY SZSE:300750 XSWX:ABBN BKK:DELTA TSE:6503 XPAR:LR SZSE:300124 SZSE:300274 VRT HUBB XKRX:247540
Traded in Other Exchanges
6Q81:Germany 6Q81:Germany
Address
3501 W. Warren Avenue, Fremont, CA, USA, 94538
Website
https://www.enovix.com
Enovix Corp is engaged in the business of advanced silicon-anode lithium-ion battery development and production. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable the widespread utilization of renewable energy.
Executives
Rajendra K Talluri director, officer: President and CEO 3501 W. WARREN AVENUE, FREMONT CA 94538
Betsy S Atkins director
Arthi Chakravarthy officer: See Remarks C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Farhan Ahmad officer: Chief Financial Officer C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Bernard Gutmann director ON SEMICONDUCTOR C/O V PECORA (M/D A700), 5005 EAST MCDOWELL ROAD, PHOENIX AZ 85008
Ralph H Schmitt officer: Chief Commercial Officer C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Thurman J Rodgers director, 10 percent owner 535 EASTVIEW WAY, WOODSIDE CA 94062
Ashok Lahiri officer: Chief Technology Officer C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Ajay Marathe officer: Chief Operating Officer C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Harrold J Rust director, officer: President and CEO C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Gardner Cameron Dales officer: Chief Commercial Officer C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Eclipse Fund Iii, L.p. 10 percent owner 514 HIGH STREET, SUITE 4, PALO ALTO CA 94301
Eclipse Gp Iii, Llc 10 percent owner 514 HIGH STREET, SUITE 4, PALO ALTO CA 94301
J Daniel Mccranie director C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Edward J Hejlek officer: See Remarks C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538